Biotest Aktiengesellschaft (FRA:BIO)
Germany · Delayed Price · Currency is EUR 42.20
0.00 (0.00%)
At close: Jun 6, 2025
FRA:BIO Market Cap
FRA:BIO has a market cap or net worth of €1.39 billion as of January 12, 2026.
Market Cap
1.39B
Enterprise Value
2.02B
Revenue
635.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
€42.20
Market Cap Chart
Since January 14, 2025, FRA:BIO's market cap has increased from 1.08B to 1.39B, an increase of 29.04%. That is a compound annual growth rate of 29.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.39B | 3.54% |
| Dec 30, 2025 | 1.34B | 24.63% |
| Jan 14, 2025 | 1.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |